Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, selectively induces growth suppression and cell death of endometrial stromal sarcoma cells in vitro

被引：0
|
作者：
Hrzenjak, Andelko [1 ]
Moinfar, Farid [1 ]
Kremser, Marie-Luise [1 ]
Strohmeier, Bettina [1 ]
Zatloukal, Kurt [1 ]
Denk, Helmut [1 ]
机构：
[1] Med Univ Graz, Dept Pathol, Graz, Austria
来源：
VIRCHOWS ARCHIV | 2007年 / 451卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：401 / 401
页数：1
相关论文
共 50 条
  • [31] Suberoylanilide hydroxamic Acid, a histone deacetylase inhibitor, alters multiple signaling pathways in hepatocellular carcinoma cell lines
    Kunnimalaiyaan, Selvi
    Sokolowski, Kevin
    Gamblin, T. Clark
    Kunnimalaiyaan, Muthusamy
    AMERICAN JOURNAL OF SURGERY, 2017, 213 (04): : 645 - 651
  • [32] Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer In Vitro and In Vivo
    Chiu, Hui-Wen
    Yeh, Ya-Ling
    Wang, Yi-Ching
    Huang, Wei-Jan
    Chen, Yi-An
    Chiou, Yi-Shiou
    Ho, Sheng-Yow
    Lin, Pinpin
    Wang, Ying-Jan
    PLOS ONE, 2013, 8 (10):
  • [33] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, attenuates postoperative cognitive dysfunction in aging mice
    Jia, Min
    Liu, Wen-Xue
    Sun, He-Liang
    Chang, Yan-Qing
    Yang, Jiao-Jiao
    Ji, Mu-Huo
    Yang, Jian-Jun
    Feng, Chen-Zhuo
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2015, 8
  • [34] Phase I clinical trial of histone deacetylase inhibitor: Suberoylanilide hydroxamic acid administered intravenously
    Kelly, WK
    Richon, VM
    O'Connor, O
    Curley, T
    MacGregor-Curtelli, B
    Tong, W
    Klang, M
    Schwartz, L
    Richardson, S
    Rosa, E
    Drobnjak, M
    Cordon-Cordo, C
    Chiao, JH
    Rifkind, R
    Marks, PA
    Scher, H
    CLINICAL CANCER RESEARCH, 2003, 9 (10) : 3578 - 3588
  • [35] Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication
    Saha, Bratati
    Parks, Robin J.
    JOURNAL OF VIROLOGY, 2019, 93 (12)
  • [36] The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces actin filament polymerization in HL-60 cells undergoing differentiation.
    Yao, Y
    Zhou, Q
    Ericson, SG
    BLOOD, 2003, 102 (11) : 206B - 206B
  • [37] Hepatoprotective Effects of Suberoylanilide Hydroxamic Acid (A Histone Deacetylase Inhibitor) in Immunological Liver Injury in Rats
    Alhaddad, A.
    Kawy, H. Abdel
    Ramadan, W.
    Abbas, A.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2019, 30 (03)
  • [38] The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)
    Marks, PA
    CELL CYCLE, 2004, 3 (05) : 534 - 535
  • [39] Phase I clinical trial of an oral histone deacetylase inhibitor: Suberoylanilide hydroxamic acid (SARA).
    Kelly, WK
    O'Connor, O
    Richon, VM
    Curley, T
    Richardson, S
    Thapi, D
    Chiao, JH
    Rifkind, RA
    Marks, PA
    Scher, HI
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6245S - 6246S
  • [40] Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells
    Zhou, Weiqiang
    Feng, Xiuyan
    Han, Han
    Guo, Shanchun
    Wang, Guangdi
    SCIENTIFIC REPORTS, 2016, 6
12345